Welcome to our dedicated page for JANUS LIVING news (Ticker: JAN), a resource for investors and traders seeking the latest updates and insights on JANUS LIVING stock.
Janus Living, Inc. reports developments as a pure-play senior housing real estate investment trust focused on senior housing communities across the United States. Company news centers on quarterly operating results, same-store revenue, occupancy and RevPOR trends, dividend declarations, liquidity actions, acquisition and investment activity, and the use of proceeds from its completed initial public offering.
Recurring updates also address Janus Living’s Class A-1 common stock trading on the New York Stock Exchange, its external management relationship with Healthpeak Properties, and capital resources such as unsecured revolving credit and term loan facilities used for general corporate purposes and portfolio growth.
Janus Living (NYSE: JAN) priced a public offering of 16,000,000 Class A-1 common shares at $29.00 per share. The company granted underwriters a 30-day option to buy up to 2,400,000 additional shares at the same public price, less underwriting discounts.
The offering is expected to close on August 12, 2026, subject to customary conditions. According to Janus Living, net proceeds will be used to pursue acquisitions and investments aligned with its criteria and for general corporate purposes. Multiple major banks are acting as bookrunners and co-managers.
Janus Living (NYSE: JAN) announced the launch of a public offering of 16,000,000 shares of its Class A-1 common stock under a Form S-11 registration filed with the SEC. The company expects to grant underwriters a 30-day option to purchase up to an additional 2,400,000 shares.
According to Janus Living, net proceeds from the proposed equity offering are expected to be used to pursue senior housing acquisition and investment opportunities that meet its criteria and for general corporate purposes. BofA Securities, J.P. Morgan, and Wells Fargo Securities are acting as lead book-running managers. The registration statement has been filed but is not yet effective.
Healthpeak Properties (NYSE:DOC) reported second quarter 2026 net income of $0.08 per share and FFO as Adjusted of $0.46 per share. Total revenues were $771.6 million versus $694.3 million a year earlier. Same-store Adjusted NOI grew 1.8%, with Outpatient Medical up 2.5%, Lab down 3.2%, and Senior Housing up 19.2%.
Healthpeak executed 1.6 million square feet of Outpatient Medical and Lab leases, increased occupancy to 90.7% in Outpatient Medical and 78.5% in Lab, and generated $1.4 billion of proceeds from recapitalizations, loan repayments, and dispositions (year-to-date $1.75 billion). Net Debt to Adjusted EBITDAre was 4.7x and liquidity was $3.4 billion.
The company closed a joint venture with Brookfield on an 86-asset, $2.1 billion outpatient portfolio, receiving approximately $1.025 billion, and entered a $20 million Northside outpatient development. Full-year 2026 EPS and FFO as Adjusted guidance midpoints were each raised by $0.02. Healthpeak also announced a new $500 million share repurchase authorization and a third-quarter cash dividend totaling $0.305 per share. Majority-owned Janus Living (NYSE:JAN) reported Q2 revenue of $216 million, up 45% year over year, and Adjusted EBITDAre of $79 million, up 34%.
Janus Living (NYSE: JAN) reported second quarter 2026 net income of $0.05 per share, versus a loss of $(0.02) a year earlier. Consolidated revenues rose 45% to $216 million and Adjusted EBITDAre increased 34% to $79 million. FFO as Adjusted reached $0.24 per share, up 40%.
Same-store adjusted NOI grew 19.2% with a 250 bps margin expansion, driven by 8.4% same-store revenue growth, 260 bps occupancy gains and 5.1% RevPOR growth. The company reported $41 million of non-refundable entrance fee sales and completed a $690 million Class A-1 equity offering.
Janus Living completed approximately $1.8 billion of senior housing acquisitions year-to-date, including $105 million in Q2 and about $1.0 billion after quarter-end, and has a further $59 million under contract. It reported no outstanding debt and unrestricted cash of $1.6 billion at June 30, 2026 and $558 million as of August 3, 2026. Full-year 2026 guidance was raised for EPS, FFO as Adjusted and same-store NOI growth.
Janus Living (NYSE: JAN) declared a monthly common stock cash dividend of $0.0475 per share for the third quarter of 2026. The dividend is equivalent to an annualized rate of $0.57 per share.
Record dates are July 17, August 14, and September 11, 2026, with corresponding payment dates of July 29, August 26, and September 23, 2026.
Janus Living (NYSE:JAN), a senior housing REIT, will report second quarter 2026 financial results after the NYSE close on Tuesday, August 4, 2026. A conference call and webcast to review financial and operating results is set for Wednesday, August 5, 2026 at 12:00 p.m. ET, with access via the company’s investor relations website, webcast link, and dial-in numbers. A webcast replay will be available through August 4, 2027.
Janus Living (NYSE: JAN) priced a public offering of 25,000,000 Class A-1 common shares at $25.00 per share. Underwriters have a 30-day option for up to 3,750,000 additional shares.
The deal is expected to close on June 4, 2026, with proceeds earmarked for acquisitions, investments, and general corporate purposes.
Janus Living (NYSE: JAN), a senior housing REIT, launched a public offering of 25,000,000 Class A-1 common shares under an SEC Form S-11 registration.
The company may grant underwriters a 30-day option for 3,750,000 additional shares and plans to use net proceeds for acquisitions, investments and general corporate purposes.
Janus Living (NYSE: JAN) declared common stock cash dividends for Q1 and Q2 2026. The Board set a pro rata Q1 dividend of $0.0174 per common share and a Q2 dividend of $0.1425 per common share, with an annualized dividend of $0.57 per share.
Both dividends share a record date of Friday, June 12, 2026 and a payment date of Wednesday, June 24, 2026.
Janus Living (NYSE: JAN)/b) reported first quarter 2026 results for the period ended March 31, 2026. Consolidated revenues were